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Abstract
Background: Saffold Virus (SAFV) is a human cardiovirus that is suspected of causing infection of the central
nervous system (CNS) in children. While recent animal studies have started to elucidate the pathogenesis of SAFV,
very little is known about the mechanisms behind it.
Method: In this study, we attempted to elucidate some of the mechanisms of the pathogenesis of SAFV in the
brain of a juvenile mouse model by using immunohistochemical methods.
Results: We first showed that SAFV is able to infect both neuronal and glial cells in the brain of 2 week-old AG129
mice. We then showed that SAFV is able to induce apoptosis in both neuronal and glial cells in the brain. Lastly,
we showed that SAFV infection does not show any signs of gross demyelination in the brain.
Conclusion: Overall, our results provide important insights into the mechanisms of SAFV in the brain.
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Findings
Saffold Virus (SAFV) is a novel human cardiovirus iden-
tified in 2007 from the stool sample of a child with a
fever of unknown origin [1]. Phylogenetic analysis re-
vealed that SAFV is closely related to Theiler’s murine
encephalomyelitis virus (TMEV) [2, 3], a virus well
studied for its neurovirulence [4]. Since then, SAFV have
been isolated in children from multiple continents [1, 5–
11] and have been shown to be highly prevalent in
humans [7]. Recently, SAFV was found in the cerebro-
spinal fluid (CSF) of a previously healthy child that
experienced sudden death [12], and in stool samples of
children with non-polio acute flaccid paralysis [6],
suggesting that the virus might be able to cause serious
invasive infection of the central nervous system (CNS)
of children [11]. TMEV, a virus similar to SAFV, is di-
vided into two strains based on their neurovirulence
after intracerebral inoculation [4]; the GDVII strain
causes acute fatal poliomyelitis, killing all infected
mice within 2 weeks, while DA strain causes milder
encephalomyelitis, which then progresses to persistent
infection and progressive demyelination reminiscent
of multiple sclerosis [13]. It has been suggested that
infection and apoptosis of neurons are responsible for
fatal outcomes, while persistence in and subsequent
apoptosis of glial cells such as oligodendrocytes is re-
sponsible for persistent demyelination [14], suggesting
that the cell type that the virus infects and persist in
hugely determines the outcome of infection.
In this short study, we wanted to examine the infectiv-
ity of SAFV in the juvenile (2 week old) brain by study-
ing the cell types it infects. We further attempted to
elucidate the effects of the infection. In order to do that,
we used AG129 mice which we have previously shown
to be a good model for SAFV infection in the CNS [15].
We used previously isolated genotype 3 SAFV [16] as a
model of SAFV infection due to its high prevalence [7].
Infectious clone used in this study was obtained as pre-
viously described in Tan et al. [15]. We then studied
brain tissue of infected animals using immunohisto-
chemical methods to elucidate some of the mechanisms
involved in the pathogenesis of SAFV. Brain tissue used
in this study were either from AG129 mice (B and K
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Universal, North Humberside, UK), or FVB/NTac mice
(Haplotype H2q) (InVivos Pte Ltd. Singapore). All animal
experimental protocols were approved by the Institu-
tional Animal Care and Use Committee (IACUC) of the
Temasek Life Sciences Laboratory, Singapore (IACUC
approval number TLL-14-025). Two week-old AG129
mice (n = 6) and 3–4 week old AG129 mice (n = 6) were
inoculated i.p. with 5 × 105 TCID50/mouse of SAFV.
Mice were sacrificed on day 6 or 35 (days post infection)
dpi as described below. FVB/NTac mice (n = 6) were in-
oculated intracranial (I.C.) with 5 × 105 TCID50/mouse
of SAFV. To obtain brains, AG129 mice were anesthe-
tized intraperitoneal (i.p.) with Ketamine (100 mg/kg)/
Xylazine (20 mg/kg) and transcardially perfused with
50 ml phosphate-buffered saline (PBS) followed by
100 ml 4% paraformaldehyde (PFA) in PBS. The mice
were then decapitated and the brains and spinal cord
were removed and post-fixed in 4% PFA overnight at
4 °C. Brains were then transferred to a solution of
20% sucrose in PBS and stored overnight at 4 °C
before freezing over liquid nitrogen and stored at −80 °C.
The brains were then embedded in Shandon M-1 Embed-
ding Matrix (Thermo, Kalamazoo, MI, USA) and sec-
tioned through a cryostat (16 um).
To assess the cell type that SAFV infects in the brain,
double labelling immunohistochemistry was carried out
on brains of 2 week-old AG129 mice inoculated i.p with
SAFV, and sacrificed 6 dpi. Briefly, tissue sections were
incubated with rabbit anti-SAFV VP1 [15] and guinea
pig anti-glial fibrillary acidic protein (GFAP) (Synaptic
Systems, Goettingen, Germany) or guinea pig anti-
neuronal nuclei (NeuN) (Synaptic Systems) overnight at
4 °C. Tissue sections were then further incubated with
secondary antibody Alexa Fluor 594 conjugated anti-
rabbit IgG and Alexa Fluor 488 conjugated anti-guinea
pig IgG (Invitrogen, Gaithersburg, USA) and counter-
stained with DAPI (Invitrogen, Gaithersburg, USA) be-
fore coverslipping with anti-fade mounting medium
(DAKO, Copenhagen, Denmark). Resulting stains were
viewed under a Leica TCS-SPE II confocal microscope.
Double labelling immunohistochemistry of infected
brains revealed that SAFV VP1 signal was found in the
olfactory/prefrontal region (Olf/PFC), midbrain, and
cerebellum, and was colocalised in both GFAP and
NeuN positive cells (Fig. 1 & Additional file 1: Figure
S1), indicating that the virus infects both neuronal and
glial cells, but neither exclusively. Our results agree with
Sorgeloos et al. [16] who showed infection of both neur-
onal and glial cells, but not with Kotani et al. [17] who
showed infection of glial cells, but not neuronal cells, in
both early adult (6 week-old) and neonatal brains of ddY
and BALB/c mice. However it should be noted that
Sorgeloos et al. [16] showed a preference to glial cells
over neuronal cells. We believe that our results are not
Fig. 1 Immunohistochemical co-localisation of SAFV VP1 with NeuN or GFAP. Brain sections of 6dpi SAFV infected 2 week-old AG129 mice were
stain with anti-SAFV VP1 and anti-NeuN or anti-GFAP. Stained SAFV infected or uninfected mice brain sections were viewed and taken with a
confocal fluorescence microscope. SAFV VP1 is labelled in red, NeuN or GFAP is labelled in green, and DAPI is labelled in blue. Arrows point at
examples of colocalisation
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contradictory, but rather compliments the data shown in
Kotani et al. [16] by highlighting the varied outcomes
seen in different strains of virus, mice breed, and age.
In order to test if SAFV causes apoptosis in both neur-
onal and glial cells, we used cleaved (activated) caspase 3
as a marker for apoptosis (due to its involvement in
both intrinsic and extrinsic pathways), detecting it
through immunohistochemistry, and co-staining it
with either NeuN or GFAP (Fig. 2) antibodies as
markers for neuronal and glial cells respectively. The
Fig. 2 Immunohistochemical co-localisation of cleaved caspase 3 with NeuN or GFAP. Brain sections tissue of 6 dpi SAFV infected or uninfected
2 week-old AG129 mice were stained with anti-cleaved caspase 3 and anti-GFAP or anti-NeuN. Resulting stain was viewed and taken with wide-
field or confocal fluorescence microscope. Cleaved caspase 3 is labelled in red, NeuN or GFAP is labelled in green, and DAPI is labelled in blue.
Arrows point at examples of colocalisation
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same immunohistochemistry protocol as above was used,
except primary antibodies used were anti-cleaved caspase
3 (Synaptic Systems) and guinea pig anti-GFAP or guinea
pig anti-NeuN (Synaptic Systems). Resulting stains were
viewed under upright fluorescence microscopy (Zeiss,
Jena, Germany) and a Leica TCS-SPE II confocal micro-
scope. SAFV infected brains showed apoptosis in similar re-
gions as viral infections, and colocalisation with both GFAP
and NeuN positive cells were observed. Control uninfected
brains showed no cleaved caspase 3 staining (Fig. 2). This
was unsurprising as we did expect the virus to behave simi-
larly (in that they induced apoptosis) to previous cell cul-
ture work [18], it was however an important finding in
understanding how the virus was affecting the brain.
Given that TMEV is able to cause multiple sclerosis
like demyelination [19], and that SAFV does infect and
induce apoptosis in glial cells, we wanted to see if SAFV
was able to cause multiple sclerosis like demyelination.
Myelin Basic Protein (MBP) was used as a marker for
myelin and was detected through immunohistochemis-
try, a method that has been shown to be highly sensitive
for detection of myelin [20], using the same protocol as
above. We found no signs of gross demyelination in
2 week-old AG129 mice on 6 dpi (Fig. 3). In order to see
if SAFV infection can cause demyelination subsequently,
we infected 3–4 week-old AG129 mice with SAFV, an
age which we have previously shown that mice initially
only show minor symptoms, but subsequently are able
to survive infection, showing no further observable
symptoms [15]. Mice were then sacrificed at 35 dpi
and brain tissue underwent immunohistochemistry
using anti-MBP (Abcam, Cambridge, UK), which
similarly revealed no signs of gross demyelination
(Fig. 3). In order to ensure that the lack of demyelin-
ation was not due to the use of an inappropriate
model, FVB/NTac mice (Haplotype H2q) were inocu-
lated I.C. with SAFV, similar to previously established
demyelination model with TMEV. Mice showed no
symptoms to 50 dpi. Brains similarly showed no signs
of demyelination (data not shown). Our results were
counter intuitive given that we showed that SAFV is
able to both infect, and induce apoptosis, in glial
cells. We would hence expect oligodendrocytes to be
affected, causing demyelination reminiscent of mul-
tiple sclerosis. It should however be noted that we
did not stain specifically for oligodendrocytes, but ra-
ther took a more general approach of staining for a
general glial marker GFAP. Kotani et al. [16], who
similarly showed SAFV infection of GFAP positive
cells, however showed no viral infection of oligo-
dendroglial suggesting viral induced apoptosis of oli-
godendrocytes is unlikely to happen in the brain of
SAFV infected animal. This could explain why we did
not observe any demyelination.
Fig. 3 Fluorescence images of MBP stained uninfected and SAFV infected brain. Brain sections of 6dpi 2 week-old AG129 mice or 35dpi 3–4
week-old AG129 mice were stained with anti-MBP antibodies. No observable demyelination was detected in any sections
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Information about SAFV infection has increased in the
past few years, with data concentrated on respiratory
and gastrointestinal tract infections [11], however data
informing CNS infection remains relatively low, despite
its importance shown by clinical samples of SAFV found
in children with neurological symptoms [6, 11, 12]. In
this short paper, we examined SAFV infection of the
brain in an animal model and presented important new
insights to the neuropathogenesis of SAFV. We showed
that SAFV is able to infect both neuronal and glial cells
in the developing brain of a mouse model, causing apop-
tosis in both. We however showed no gross demyelin-
ation in the brains of the infected animals. We hence
provided important insights, extending the findings of
our previous paper [15], and provided a strong basis on
which the mechanisms of neuropathogenesis of SAFV
can be further examined.
Additional file
Additional file 1: Figure S1. High magnification micrograph of
Immunohistochemical stain showing co-localisation of SAFV VP1 with
NeuN or GFAP. Brain sections tissue of 6dpi SAFV infected 2 week-old
AG129 mice were stain with anti-SAFV VP1 and anti-NeuN or anti-GFAP.
Stained SAFV infected or uninfected mice brain sections were viewed and
taken with a confocal fluorescence microscope. SAFV VP1 is labelled in red,
NeuN or GFAP is labelled in green, and DAPI is labelled in blue. (JPG 297 kb)
Acknowledgements
This work was supported by Temasek Lifesciences Laboratory. We thank
Kabilan and Govindarajan for their assistance with the maintenance of the
mouse strains. We thank Chua Kaw Bing for their generous gift of reagents.
Authors’ contributions
SZKT and MP designed the study. SZKT performed the experiments. SZKT,
MP analyzed the data. SZKT wrote the paper and MP reviewed the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 April 2016 Accepted: 21 November 2016
References
1. Jones MS, Lukashov VV, Ganac RD, Schnurr DP. Discovery of a novel human
picornavirus in a stool sample from a pediatric patient presenting with fever
of unknown origin. J Clin Microbiol. 2007;45:2144–50.
2. Liang Z, Kumar ASM, Jones MS, Knowles NJ, Lipton HL. Phylogenetic
analysis of the species theilovirus: emerging murine and human pathogens.
J Virol. 2008;82:11545–54.
3. Chiu CY, Greninger AL, Kanada K, Kwok T, Fischer KF, Runckel C, et al.
Identification of cardioviruses related to Theiler’s murine encephalomyelitis
virus in human infections. Proc Natl Acad Sci U S A. 2008;105:14124–9.
4. Jarousse N, Syan S, Martinat C, Brahic M. The neurovirulence of the DA and
GDVII strains of Theiler’s virus correlates with their ability to infect cultured
neurons. J Virol. 1998;72:7213–20.
5. Abed Y, Boivin G. New Saffold cardioviruses in 3 children. Canada Emerg
Infect Dis. 2008;14:834–6.
6. Blinkova O, Kapoor A, Victoria J, Jones M, Wolfe N, Naeem A, et al.
Cardioviruses are genetically diverse and cause common enteric infections
in South Asian children. J Virol. 2009;83:4631–41.
7. Zoll J, Erkens Hulshof S, Lanke K, Verduyn Lunel F, Melchers WJ,
Schoondermark-van de Ven E, et al. Saffold virus, a human Theiler’s-like
cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog.
2009;5:e1000416.
8. Chiu CY, Greninger AL, Chen EC, Haggerty TD, Parsonnet J, Delwart E, et al.
Cultivation and serological characterization of a human Theiler’s-like
cardiovirus associated with diarrheal disease. J Virol. 2010;84:4407–14.
9. Ren L, Gonzalez R, Xie Z, Xiao Y, Li Y, Liu C, et al. Saffold cardioviruses
of 3 lineages in children with respiratory tract infections, Beijing, China.
Emerg Infect Dis. 2010;16:1158–61.
10. Drexler JF, de Souza Luna LK, Stöcker A, Almeida PS, Ribeiro TCM, Petersen N,
et al. Circulation of 3 lineages of a novel saffold cardiovirus in humans.
Emerg Infect Dis. 2008;14:1398–405.
11. Zhang X-A, Lu Q-B, Wo Y, Zhao J, Huang D-D, Guo CT, et al. Prevalence and
genetic characteristics of Saffold cardiovirus in China from 2009 to 2012.
Sci Rep. 2015;5:7704.
12. Nielsen ACY, Böttiger B, Banner J, Hoffmann T, Nielsen LP. Serious invasive
Saffold virus infections in children, 2009. Emerg Infect Dis. 2012;18:7–12.
13. Lipton HL. Theiler’s virus infection in mice: an unusual biphasic disease
process leading to demyelination. Infect Immun. 1975;11:1147–55.
14. Tsunoda I, Kurtz CI, Fujinami RS. Apoptosis in acute and chronic central
nervous system disease induced by Theiler’s murine encephalomyelitis virus.
Virology. 1997;228:388–93.
15. Tan ZS, Chua BK, Xu Y, Prabakaran M. The pathogenesis of Saffold virus in
AG129 mice and the effects of its truncated L protein in the central nervous
system. Viruses. 2016;8:24.
16. Sorgeloos F, Lardinois C, Jacobs S, Kuppeveld FJMV, Kaspers B, Michiels T.
Neurotropism of Saffold virus in a mouse model. J Gen Virol. 2016;97:1350–5.
17. Kotani O, Naeem A, Suzuki T, Iwata-Yoshikawa N, Sato Y, Nakajima N, et al.
Neuropathogenicity of two saffold virus type 3 isolates in mouse models.
PLoS One. 2016;11:e0148184.
18. Xu Y, Victorio CBL, Ng Q, Tan YJ, Chua KB. Saffold virus is able to
productively infect primate and rodent cell lines and induces apoptosis in
these cells. Emerg Microbes Infect. 2014;3:e15.
19. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. Theiler’s virus
infection: a model for multiple sclerosis. Clin Microbiol Rev. 2004;17:174–207.
20. Bodhireddy SR, Lyman WD, Rashbaum WK, Weidenheim KM.
Immunohistochemical detection of myelin basic protein is a sensitive
marker of myelination in second trimester human fetal spinal cord.
J Neuropathol Exp Neurol. 1994;53:144–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Tan and Prabakaran Virology Journal  (2016) 13:191 Page 5 of 5
